title: Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.
abstract: Immunomodulatory agents potentially represent a new class of broad-spectrum antimicrobials. Here, we demonstrate that prophylaxis with immunomodulatory cytosine-phosphate-guanidine (CpG) oligodeoxynucleotide (ODN), a toll-like receptor 9 (TLR9) agonist, confers protection against Yersinia pestis, the etiologic agent of plague. The data establish that intranasal administration of CpG ODN 1 day prior to lethal pulmonary exposure to Y. pestis strain KIM D27 significantly improves survival of C57BL/6 mice and reduces bacterial growth in hepatic tissue, despite paradoxically increasing bacterial growth in the lung. All of these CpG ODN-mediated impacts, including the increased pulmonary burden, are TLR9 dependent, as they are not observed in TLR9-deficient mice. The capacity of prophylactic intranasal CpG ODN to enhance survival does not require adaptive immunity, as it is evident in mice lacking B and/or T cells; however, the presence of T cells improves long-term survival. The prophylactic regimen also improves survival and reduces hepatic bacterial burden in mice challenged intraperitoneally with KIM D27, indicating that intranasal delivery of CpG ODN has systemic impacts. Indeed, intranasal prophylaxis with CpG ODN provides significant protection against subcutaneous challenge with Y. pestis strain CO92 even though it fails to protect mice from intranasal challenge with that fully virulent strain.
authors.affiliation: Trudeau Institute, Saranac Lake, New York, USA.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Hickey
authors.forename: Jr-Shiuan
authors.initials: JS
authors.lastname: Lin
authors.forename: Lawrence W
authors.initials: LW
authors.lastname: Kummer
authors.forename: Frank M
authors.initials: FM
authors.lastname: Szaba
authors.forename: Debra K
authors.initials: DK
authors.lastname: Duso
authors.forename: Michael
authors.initials: M
authors.lastname: Tighe
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Parent
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Smiley
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000494:pharmacology; D000281:Administration, Intranasal; D000818:Animals; D005786:Gene Expression Regulation / Q000276:immunology; D008099:Liver / Q000382:microbiology; D008168:Lung / Q000166:cytology / Q000382:microbiology; D051379:Mice; D008810:Mice, Inbred C57BL; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage* / Q000494:pharmacology; D010930:Plague / Q000517:prevention & control*; D013047:Specific Pathogen-Free Organisms; D051217:Toll-Like Receptor 9 / Q000819:agonists / Q000235:genetics / Q000378:metabolism; D014774:Virulence; D015010:Yersinia pestis / Q000276:immunology / Q000472:pathogenicity
chemical_list: D000276:Adjuvants, Immunologic; C408982:CPG-oligonucleotide; D009838:Oligodeoxyribonucleotides; C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9
references.citation: J Immunol. 1999 Feb 15;162(4):2291-8
references.pmid: 9973506
references.citation: Infect Immun. 1994 Oct;62(10):4192-201
references.pmid: 7927675
references.citation: Infect Immun. 2006 May;74(5):3068-70
references.pmid: 16622253
references.citation: Clin Vaccine Immunol. 2012 May;19(5):675-83
references.pmid: 22441390
references.citation: FEMS Immunol Med Microbiol. 1999 Feb;23(2):107-13
references.pmid: 10076907
references.citation: Infect Immun. 1984 Sep;45(3):655-9
references.pmid: 6469352
references.citation: Am J Trop Med Hyg. 1997 Apr;56(4):471-3
references.pmid: 9158060
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5526-30
references.pmid: 16567636
references.citation: Vaccine. 2011 Sep 16;29(40):6866-73
references.pmid: 21803090
references.citation: Nature. 1995 Apr 6;374(6522):546-9
references.pmid: 7700380
references.citation: Immunol Rev. 2008 Oct;225:256-71
references.pmid: 18837787
references.citation: Lancet. 2007 Apr 7;369(9568):1196-207
references.pmid: 17416264
references.citation: Curr Opin Microbiol. 2006 Feb;9(1):55-61
references.pmid: 16413818
references.citation: J Immunol. 2001 Nov 1;167(9):4878-86
references.pmid: 11673492
references.citation: Infect Immun. 1998 Dec;66(12):5755-62
references.pmid: 9826351
references.citation: Infect Immun. 2010 Feb;78(2):773-82
references.pmid: 19933831
references.citation: Clin Vaccine Immunol. 2009 Dec;16(12):1720-7
references.pmid: 19828767
references.citation: Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91
references.pmid: 16306265
references.citation: Eur J Immunol. 2001 Jul;31(7):2154-63
references.pmid: 11449369
references.citation: Nature. 2000 Dec 7;408(6813):740-5
references.pmid: 11130078
references.citation: Clin Infect Dis. 2005 Apr 15;40(8):1166-72
references.pmid: 15791518
references.citation: Mol Microbiol. 2004 Jun;52(5):1363-73
references.pmid: 15165239
references.citation: Expert Rev Vaccines. 2008 Mar;7(2):209-21
references.pmid: 18324890
references.citation: Nat Rev Immunol. 2004 Apr;4(4):249-58
references.pmid: 15057783
references.citation: Infect Immun. 2008 Dec;76(12):5843-52
references.pmid: 18852251
references.citation: Respir Res. 2009 Sep 23;10:84
references.pmid: 19772669
references.citation: Vaccine. 2011 Sep 9;29(39):6802-9
references.pmid: 21199697
references.citation: Infect Immun. 2005 Nov;73(11):7304-10
references.pmid: 16239527
references.citation: Vaccine. 2008 Nov 25;26(50):6329-37
references.pmid: 18832004
references.citation: J Immunol. 2004 Oct 15;173(8):5148-55
references.pmid: 15470059
references.citation: PLoS Pathog. 2012;8(7):e1002817
references.pmid: 22911267
references.citation: Infect Immun. 2009 Nov;77(11):4750-60
references.pmid: 19720755
references.citation: JAMA. 2000 May 3;283(17):2281-90
references.pmid: 10807389
references.citation: Infect Immun. 2010 Jan;78(1):220-30
references.pmid: 19841077
references.citation: Lancet. 2000 Jan 8;355(9198):111-3
references.pmid: 10675169
references.citation: Infect Immun. 2004 Aug;72(8):4494-502
references.pmid: 15271908
references.citation: Infect Immun. 2009 Oct;77(10):4295-304
references.pmid: 19620344
references.citation: Infect Immun. 2003 Oct;71(10):5892-9
references.pmid: 14500510
references.citation: Infect Immun. 2006 Mar;74(3):1944-8
references.pmid: 16495571
references.citation: Clin Vaccine Immunol. 2009 Oct;16(10):1457-66
references.pmid: 19710295
references.citation: J Cell Biol. 2002 Aug 5;158(3):401-8
references.pmid: 12163464
references.citation: PLoS One. 2012;7(3):e34176
references.pmid: 22448290
references.citation: J Immunol. 2001 Oct 1;167(7):3555-8
references.pmid: 11564765
references.citation: Microbiology (Reading). 2008 Jul;154(Pt 7):2131-2138
references.pmid: 18599840
references.citation: Infect Immun. 2002 Aug;70(8):4092-8
references.pmid: 12117916
references.citation: Infect Immun. 2003 Apr;71(4):2234-8
references.pmid: 12654847
references.citation: J Infect Dis. 2011 Aug 15;204(4):636-44
references.pmid: 21791666
references.citation: Eur J Immunol. 1999 Apr;29(4):1209-18
references.pmid: 10229088
references.citation: Clin Microbiol Rev. 1997 Jan;10(1):35-66
references.pmid: 8993858
references.citation: Infect Immun. 2006 Jun;74(6):3381-6
references.pmid: 16714568
references.citation: Infect Immun. 2007 Feb;75(2):878-85
references.pmid: 17118978
references.citation: J Innate Immun. 2010;2(2):144-59
references.pmid: 20375632
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9237-42
references.pmid: 11470918
references.citation: Annu Rev Microbiol. 2005;59:69-89
references.pmid: 15847602
references.citation: Expert Opin Biol Ther. 2004 Jun;4(6):965-73
references.pmid: 15174978
references.citation: Adv Prev Med. 2012;2012:731604
references.pmid: 22028978
references.citation: Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):457-61
references.pmid: 10224474
references.citation: J Immune Based Ther Vaccines. 2010 Feb 05;8(1):2
references.pmid: 20181102
references.citation: Vaccine. 2011 Jun 24;29(29-30):4771-7
references.pmid: 21570437
references.citation: Monogr Ser World Health Organ. 1959;58(43):1001-19
references.pmid: 13669509
references.citation: J Immunol. 2011 Feb 1;186(3):1675-84
references.pmid: 21172869
references.citation: Nat Immunol. 2006 Oct;7(10):1066-73
references.pmid: 16980981